Company data
ANI Pharmaceuticals, Inc. employees and revenue per employee
ANIP · Drug Manufacturers - Specialty & Generic · $1.68B market cap
ANI Pharmaceuticals, Inc. had 970 employees at the end of fiscal Dec 2025, up 8.1% from a year earlier. Revenue for the year was $883M, up 43.8% from a year earlier, or $911K per employee. Revenue and headcount both grew, and revenue grew faster.
Employees
970
+8.1% YoY
Revenue
$883M
+43.8% YoY
Revenue / employee
$911K
Peer median $825K
Rank in industry
6 of 17
Drug Manufacturers - Specialty & Generic
Headcount against revenue
Both lines start at 100 in the first year we hold, so you can see which one grew faster.
Hover a year for the numbers.
| Year ending | Employees | Revenue | Per employee | Staff YoY | Revenue YoY |
|---|---|---|---|---|---|
| Dec 2025 | 970 | $883M | $911K | +8.1% | +43.8% |
| Dec 2024 | 897 | $614M | $685K | +39.7% | +26.2% |
| Dec 2023 | 642 | $487M | $758K | +7.0% | +53.9% |
| Dec 2022 | 600 | $316M | $527K | -0.2% | +46.4% |
| Dec 2021 | 601 | $216M | $360K | +62.9% | +3.7% |
| Dec 2020 | 369 | $208M | $565K | +9.2% | +0.9% |
| Dec 2019 | 338 | $207M | $611K | +13.0% | +2.5% |
| Dec 2018 | 299 | $202M | $674K | +72.8% | +14.0% |
| Dec 2017 | 173 | $177M | $1.02M | +21.0% | +37.5% |
| Dec 2016 | 143 | $129M | $899K | — | — |
Open roles: we have not matched a verified job board for this company yet.
ANI Pharmaceuticals, Inc. against similar companies
The closest industry peers by revenue, from Drug Manufacturers - Specialty & Generic.
| Company | Employees | Revenue | Revenue / employee | Shape |
|---|---|---|---|---|
| COLL Collegium Pharmaceutical, Inc. | 423 | $781M | $1.85M | Efficient growth |
| INDV Indivior Pharmaceuticals Inc | 827 | $1.24B | $1.50M | Leaner |
| LNTH Lantheus Holdings, Inc. | 1,193 | $1.54B | $1.29M | Hiring ahead |
| SUPN Supernus Pharmaceuticals, Inc. | 778 | $719M | $924K | Hiring ahead |
| ANIP ANI Pharmaceuticals, Inc. | 970 | $883M | $911K | Efficient growth |
| PCRX Pacira BioSciences, Inc. | 825 | $726M | $880K | Hiring ahead |
| EBS Emergent BioSolutions Inc. | 900 | $743M | $825K | Contracting |
| PAHC Phibro Animal Health Corporation | 2,605 | $1.52B | $583K | Efficient growth |
| AMPH Amphastar Pharmaceuticals, Inc. | 1,976 | $720M | $364K | Contracting |
Questions about ANI Pharmaceuticals, Inc.
- How many employees does ANI Pharmaceuticals, Inc. have?
- ANI Pharmaceuticals, Inc. reported 970 employees for the fiscal year ending Dec 2025, in the annual report it filed on February 27, 2026. That is up 8.1% from a year earlier.
- What is ANI Pharmaceuticals, Inc.'s revenue per employee?
- ANI Pharmaceuticals, Inc. brought in $883M of revenue in fiscal Dec 2025, which is $911K per employee. That ranks 6 of 17 companies we track in Drug Manufacturers - Specialty & Generic, where the median is $825K.
- Where do these numbers come from?
- Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.
Free game
Think you can pick better than the S&P 500?
Pick 15 stocks, lock them in, and we score them against the index every trading day for ten years. Free, with a public leaderboard.
Enter the challengeMore data
Compare ANIP with the rest of the market
See who earns the most per employee, who is hiring, and who is cutting, across every company we track.
Source: employee counts and revenue as stated in ANI Pharmaceuticals, Inc.'s annual reports (Form 10-K), latest filed February 27, 2026. This is data, not a recommendation to buy or sell ANIP.